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Background: The human Aldoketoreductase 1B10 gene (AKR1B10) encodes one of the enzymes belonging to the
family of aldoketoreductases and may be involved in detoxification of nutrients during digestion. Further, AKR1B10
mRNA (messenger ribonucleic acid) expression was diminished in brain regions potentially involved in the
regulation of eating behavior in rats which are more sensitive to cocaine and alcohol. We hypothesized that the
human AKR1B10 gene may also play a role in the regulation of human eating behavior.
Results: We investigated the effects of 5 genetic variants of AKR1B10 on human eating behavior among 548 subjects
from a German self-contained population, the Sorbs, and in 350 subjects from another independent German cohort.
Among the Sorbs, we observed nominal associations with disinhibition at the 5′ untranslated region (5′ UTR) variant
rs10232478 and the intragenic variants rs1834150 and rs782881 (all P≤ 0.05). Further, we detected a relationship of
rs1834150 and rs782881 with waist, smoking consumption (rs782881) and coffee consumption (rs1834150) (all P ≤ 0.05).
Albeit non-significant, replication analyses revealed similar effect directions for disinhibition at rs1834150 (combined
P = 0.0096). Moreover, in the replication cohort we found rs1834150 related to increased restraint scores with a similar
direction as in the Sorbs (combined P = 0.0072).
Conclusion: Our data suggest that genetic variants in the AKR1B10 locus may influence human eating behavior.
Keywords: Eating behavior, Association, Restraint, Disinhibition, Genetic variantsBackground
The human aldoketoreductase 1B10 (AKR1B10) was iden-
tified in human hepatocellular cancer as a member of the
AKR superfamily [1]. The NADP(H)-dependent (nicotina-
mide adenine dinucleotide phosphate) enzyme is mostly
expressed in the gastrointestinal tract, particularly in the
small intestine, and colon as well as adrenal gland [1,2]. It
reduces a wide spectrum of natural or synthetic harmful
components present in daily nutrients and may hence be
involved in detoxification mechanisms [3]. AKR1B10 is
further involved in fatty acid biosynthesis [4,5] as well as
the prostaglandin and retinoid acid metabolism [6-8]. It
was shown that up-regulation of the mRNA or protein ex-
pression results in a tumorigenic cell proliferation [7] in
several types of cancers such as liver [9], lung [10] and
breast cancer [11]. Interestingly, its up-regulation was* Correspondence: Yvonne.Boettcher@medizin.uni-leipzig.de
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unless otherwise stated.triggered by smoking in healthy individuals [10,12] or in
cells treated with several toxic chemical compounds such
as the antioxidant ethoxiquin or lipid derived aldehydes
like HNE (Hydroxynonenal) [13], which are also present
in daily food. This suggests protective effects of AKR1B10
against toxic nutrient-specific aldehydes [3,14]. In
addition, Akr1b10 expression was shown to be lower in
brain of Lewis rats (LEW) that are more sensitive to co-
caine or ethanol compared to a control group of rats
(Fischer 344 (F344)) [15]. Higueras-Matas et al. (2011)
[15] observed a decreased expression of Akr1b10 in nu-
cleus accumbens and the frontal cortex, areas suggested to
be involved in eating behavior. Taken together, (i) the im-
portant role of AKR1B10 in detoxifying aldehydes and sev-
eral other deleterious compounds during digestion and (ii)
its putative central effects in brain regions potentially in-
volved in eating behavior allowed us to hypothesize that
AKR1B10 may play a role in human eating behavior.
There is a good evidence for the role of genetics in hu-
man eating behavior [16-19] or in altered eating behaviorThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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fat mass and obesity associated gene (FTO) were not only
associated with higher body mass index (BMI) but also with
loss of control over eating and selection of food higher in
calories and fat [21-23]. Single nucleotide polymorphisms
(SNP) in the glutamate decarboxylase gene (GAD2) were
significantly associated with increased disinhibition and
hunger in women from the Quebec Family Study [24] while
a promoter SNP was related to disinhibition and hunger
scores in morbidly obese patients from a French cohort
[25]. Meyre et al. (2005) further described the promoter
variant in GAD2 associated with lower birth weight and
subsequently higher BMI Z-Scores in French children [26].
Further, genetic variants within the leptin gene (LEP) and
cholecystokinin gene (CCK) were shown to be associated
with “snacking behavior” [27] and bigger meal sizes [28].
Dotson and colleagues (2010 & 2008) [16,29] found that
the density of bitter taste receptors is partially determined
by genetic factors influencing eating behavior through sen-
sitivity to bitterness. In the present study we investigated
SNP markers within the AKR1B10 gene and in the up-
stream untranslated regulatory region. We evaluated its
genetic association with human eating behavior, a variety of
metabolic and anthropometric phenotypes, and consump-
tion of consumer goods such as alcohol intake, smoking be-
havior and coffee consumption. To the best of our
knowledge this is the first study investigating AKR1B10 var-
iants and their potential relationship with anthropometric
and metabolic parameters as well as eating behavior traits.
Methods
Subjects
Sorbs
In the present study we used a self-contained population,
the Sorbs from Germany, comprising 1046 individuals as
described earlier [30] (The entire recruitment was done by
Dr. Anke Tönjes and Dr. Jan Halbritter (University of Leip-
zig, Germany). Sampling was carried out population based.
Exclusion criteria were age under 18 years and pregnancy.
No specific inclusion criteria in regard to disease states
were considered. For subjects recruitment, the study was
advertised by flyers, newspapers, radio and by local general
practitioners. 618 Sorbs out of 1046 completed the
German version of the three factor eating questionnaire
(FEV) which determines the three main eating behavior
factors - disinhibition, hunger and restraint as described in
detail elsewhere [18,31,32]. In the here presented study
type 2 diabetes (T2D) was the only exclusion criterion be-
cause diabetic individuals usually control their food intake
according to specific nutrition plans. Therefore, 70 Sub-
jects with T2D have been excluded from the study. Dia-
betes was diagnosed based on a 75 g oral glucose tolerance
test (OGTT) and the definition of T2D according to ADA
criteria [33]. Finally, the study included 548 subjects (346women and 202 men). No further exclusion criteria were
used in this study. All individuals underwent extensive
phenotyping [30,34] including a standardized interview for
past medical history, family history, measurements of
anthropometric parameters (waist, hip, BMI, waist to hip
ratio (WHR)), measurements of glucose and insulin metab-
olism (75 g OGTT, blood glucose and insulin levels at sev-
eral time points (0, 30 and 120 min after meal) [35]) and
measurements of lipid metabolism (total cholesterol levels,
high and low density lipoprotein cholesterol levels (HDL-C
and LDL-C), and triglyceride concentration (TG)) [36].
Insulin was measured with the Auto-DELFIA Insulin
assay (PerkinElmer Life and Analytical Sciences, Turku,
Finland). Serum glucose was measured by the hexokinase
method (Automated analyser Modular, Roche Diagnostics,
Mannheim, Germany). Total serum cholesterol and TG
concentrations were measured by standard enzymatic
methods (CHOD-PAP and GPO-PAP; Roche Diagnostics).
Serum HDL and LDL cholesterol concentrations were
determined with commercial homogeneous direct meas-
urement methods (Roche Diagnostics). All assays were
performed in an automated clinical chemistry analyzer
(Hitachi/ Roche Diagnostics) at the Institute of Laboratory
Medicine, University Hospital Leipzig. The main character-
istics of the participants are summarized in Table 1.Consumption of consumer goods in sorbs
Consumption of consumer goods such as coffee and
alcohol consumption as well as smoking behavior were
assessed by standardized interviews for all subjects
(no previously validated questionnaire was used). To esti-
mate coffee and alcohol intake, subjects were asked
for average intake but not for a certain time period
(alcohol: 1) none; 2) occasionally at special events; 3) 2–3
glasses of wine or bottle of beer per week; 4) 1 glass of wine
or bottle of beer per day; 5) 2 glasses of wine or bottles of
beer per day; 6) more than 3 glasses of wine or bottles of
beer per day; coffee: number of cups per day) [30,37]. We
did not account for different contents of alcohol per glass/
bottle or caffeine content per cup. Smoking behavior was
obtained by asking for the time period of smoking (cur-
rently, former, never) and the number of cigarettes per day.
It was not accounted for occasional smokers.Replication cohort
For replication purposes we used another independent
German cohort as described elsewhere [18] including
350 healthy individuals (152 women and 198 men). Briefly,
phenotyping included anthropometric measurements (BMI
and weight), age, sex and data for eating behavior, which
were assessed using the German version of the three factor
eating questionnaire (FEV) [31]. The main characteristics of
the subjects are summarized in Table 1.
Table 1 Main characteristics of the study populations
Sorbs Replication
N total 548 350
Age (years) 48 ± 16 27 ± 5
BMI (kg/m2) 26.1 ± 4.4 27.0 ± 6.2
Waist-Hip Ratio 0.86 ± 0.1 n.a.
Waist circumference 88.39 ± 13.02 n.a.
Hip circumference 102.65 ± 8.09 n.a.
Fasting plasma glucose (mmol/l) 5.24 ± 0.49 n.a.
30 min plasma glucose (mmol/l) 8.36 ± 1.65 n.a.
120 min plasme glucose (mmol/l) 5.41 ± 1.66 n.a.
Fasting plasma insulin (pmol/l) 37.74 ± 22.71 n.a.
30 min plasma insulin (pmol/l) 290.32 ± 173.40 n.a.
120 plasma glucose (pmol/l) 173.40 ± 156.88 n.a.
Total cholesterol (mmol/l) 5.34 ± 1.08 n.a.
HDL-cholsterol (mmol/l) 1.69 ± 0.41 n.a.
LDL-cholesterol (mmol/l) 3.37 ± 0.99 n.a.
Triglycerides (mmol/l) 1.23 ± 0.83 n.a.
Disinhibition 4.3 ± 3.0 6.2 ± 3.2
Hunger 3.9 ± 2.9 5.5 ± 3.4
Restraint 7.9 ± 4.8 6.1 ± 4.4
Coffee intake (cups per day) 2 ± 1 n.a
Alcohol intake (glasses per week) 3 ± 1 n.a.
Smoking behavior (cigarettes per day) 10 ± 8 n.a.
Data are presented as mean ± standard deviation (SD) BMI: Body Mass Index;
WHR: waist-to-hip ratio. Women/men per population is as follows: Sorbs
(346 women, 202 men); Replication (152 women, 198 men) n.a.: not available.
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Genotyping
Five AKR1B10 SNPs (rs1834150; rs782881; rs3778828;
rs4732036; UTR SNP rs10232478) were selected for the
analysis. We selected tagging SNPs for our analysis which
are in linkage disequilibrium (LD) with several other SNPs
within and around the AKR1B10 locus to enlarge the
probability to find associating variants in the gene without
the need to analyze all existing SNPs. The genotype infor-
mation for rs10232478 was extracted from genome wide
Affymetrix SNP data [38] for the Sorbs and individually
genotyped in the replication cohort. The remaining vari-
ants were taken from the HapMap database (r2 > 0.8,
minor allele frequency (MAF) < 0.05) and genotyped using
the KASPar SNP genotyping system (KBiosiences Ltd.,
Hoddesdon, United Kingdom) according to manufac-
turer’s protocol (TD PCR (touch down polymerase chain
reaction) with following conditions: 94°C for 15 sec, 94°C
for 20 sec, 61°C for 60 sec, for 10 cycles, drop down 0.6°C
per cycle, 94°C for 10 sec, 55°C for 60 sec, for 26 cycles).Genomic deoxyribonucleic acid (DNA) for genotyping
was extracted from blood with QIAmp DNA Blood Midi
Kit (Qiagen, Hilden, Germany) according to the manufac-
turer’s protocol. Fluorescence was detected using ABI
PRISM 7500 Sequence Detecting System. To guarantee
genotyping reproducibility, a random ~5% of the samples
were re-genotyped in all SNPs; all genotypes matched ini-
tial designated genotypes. The average genotyping success
rate for all analyzed SNPs was 96.38%.
Statistical analysis
Statistical analyses were performed using the SPSS statis-
tics software version 20.0 (SPSS, Inc.; Chicago, IL). Non-
normally distributed parameters were log10-transformed
to approximate normal distribution prior to analysis. All
variants were in Hardy-Weinberg-Equilibrium. Genetic
association with eating behavior traits, anthropometric
and metabolic phenotypes were calculated using linear
regression models adjusted for age, gender and lnBMI
(except for BMI). Cronbach’s alpha coefficients were
calculated to measure the internal reliability of the three
eating behavior subscales. Coffee consumption was de-
fined as cups per day, smoking behavior as number of
cigarettes per day and alcohol intake as number of
glasses per week. We did not account for different con-
tents of alcohol per glass/bottle or caffeine content per
cup. P-values for smoking, alcohol intake and coffee
consumption were corrected for age and gender. Addi-
tive, dominant and recessive models of inheritance were
tested. To correct for multiple testing we lowered the
significance threshold to (0.05/(315 tests) = 1.6×10−4).
All P-values > 1.6×10−4 but ≤ 0.05 were considered to be
of nominal statistical significance. All P-values are pro-
vided uncorrected for multiple testing. Meta-analyses
were performed using METAL [39]. All analyses were
standardized to the minor allele (plus strand).
Results
Association analysis in sorbs
We observed nominally significant associations with disin-
hibition at the variant rs10232478 located in the 5′ un-
translated region and the intronic SNPs rs1834150 and
rs782881 (Table 2). For each of the variants the minor al-
leles were related to increased disinhibition scores. A
trend for nominal association with restraint scores was
shown at rs3778828. No relationships were obtained for
any of the variants with hunger (Table 2).
Furthermore, we observed decreased waist circumfer-
ence in homozygous minor allele carriers when applying
recessive inheritance models, respectively (rs782881
P = 0.001; rs1834150 P = 0.004; Table 2). A slightly in-
creased coffee consumption was detected in homozy-
gous or heterozygous minor allele carriers of rs1834150
(P = 0.043; Table 2). Further, while carriers of the minor
Table 2 Association analysis of AKR1B10 variants in the Sorbs population
AKR1B10 genotype
rs10232478 rs782881 rs1834150 rs3778828 rs4732036
Genotype (N) CC (76) CT (230) TT (195) CC (114) AC (263) AA (150) TT (115) TA (257) AA (171) AA (37) GA (201) GG (293) CC (49) TC (210) TT (280)
Association analysis with anthropometric traits
BMI (kg/m2) 25.96 ± 3.83 26.42 ± 4.94 25.99 ± 4.09 26.5 ± 4.9 25.9 ± 4.4 26.2 ± 4.1 26.2 ± 4.1 26 ± 4.5 26.1 ± 4.1 26.4 ± 4 25.9 ± 4 26.2 ± 4.7 26.0 ± 4.9 25.9 ± 4.2 26.1 ± 4.4
p-value n.s. n.s. n.s. n.s. n.s.
Waist (cm) 87.17 ± 11.70 88.92 ± 13.6 88.91 ± 13.37 87.80 ± 13.1 88.22 ± 12.8 89.18 ± 13.3 87.20 ± 11.8 88.64 ± 13.2 88.76 ± 13.2 87.78 ± 12.6 88.60 ± 12.8 88.20 ± 13.2 88.12 ± 14.9 88.46 ± 12.9 88.33 ± 12.8
p-value n.s. "0.001 "0.004 n.s. n.s.
Hip (cm) 101.6 ± 7.3 103.6 ± 9.2 102.4 ± 7.4 102.61 ± 9.1 106.22 ± 55.8 102.77 ± 7.4 102.37 ± 7.8 106.39 ± 56.4 102.39 ± 7.4 104.14 ± 7.5 102.17 ± 7 105.99 ± 53.0 102.35 ± 9.4 106.67 ± 62.3 102.82 ± 7.9
p-value n.s. n.s. n.s. n.s. n.s.
WHR 0.86 ± 0.09 0.86 ± 0.09 0.87 ± 0.1 0.85 ± 0.1 0.85 ± 0.1 0.87 ± 0.1 0.85 ± 0.1 0.86 ± 0.1 0.86 ± 0.1 0.84 ± 0.1 0.86 ± 0.1 0.85 ± 0.1 0.86 ± 0.1 0.86 ± 0.1 0.86 ± 0.1
p-value n.s. n.s. n.s. n.s. n.s.
Association analysis with eating behavior factors
Disinhibition 4.95 ± 2.88 4.53 ± 3.16 3.81 ± 2.7 4.9 ± 3.11 4.3 ± 3.02 4.04 ± 2.92 4.93 ± 3.16 4.33 ± 2.95 3.94 ± 2.89 4.65 ± 3.04 4.25 ± 2.99 4.41 ± 3.03 4.29 ± 2.92 4.29 ± 3.12 4.43 ± 2.94
p-value °0.003 °0.032 "0.037 °0.006 #0.027 "0.022 n.s. n.s.
Hunger 4.09 ± 2.94 4.04 ± 2.84 3.66 ± 2.66 4.26 ± 2.86 3.83 ± 2.86 3.92 ± 3.10 4.17 ± 2.88 3.85 ± 2.85 3.95 ± 3.04 3.99 ± 3.16 3.99 ± 2.81 3.93 ± 2.98 3.84 ± 2.8 4.07 ± 3.05 3.88 ± 2.86
p-value n.s. n.s. n.s. n.s. n.s.
Restraint 8.79 ± 5.32 7.86 ± 4.73 7.62 ± 4.92 8.52 ± 5.13 7.71 ± 4.67 7.65 ± 5.05 8.52 ± 5.09 7.82 ± 4.77 7.6 ± 4.9 7.42 ± 5.03 7.53 ± 4.88 8.31 ± 4.83 7.8 ± 4.37 7.57 ± 4.88 8.24 ± 4.96
p-value n.s. n.s. n.s. °0.048 n.s.
Association analysis with consumer goods
Smoking 10.04 ± 8.79 10.07 ± 8.13 9.45 ± 8.09 9.91 ± 8.9 10.34 ± 8.18 8.4 ± 7.4 10.6 ± 9.31 9.58 ± 7.95 10.02 ± 8.48 4.67 ± 3.33 10.32 ± 8.98 9.89 ± 8.23 11.94 ± 8.44 9.39 ± 8.35 9.89 ± 8.52
p-value n.s. #0.044 n.s. n.s. n.s.
Alcohol 2.83 ± 1.2 2.78 ± 1.17 2.82 ± 1.2 2.88 ± 1.18 2.76 ± 1.11 2.79 ± 1.28 2.84 ± 1.23 2.77 ± 1.12 2.79 ± 1.23 2.84 ± 1.30 2.8 ± 1.22 2.77 ± 1.14 2.9 ± 1.19 2.82 ± 1.19 2.75 ± 1.17
p-value n.s. n.s. n.s. n.s. n.s.
Coffee 1.79 ± 0.72 1.79 ± 0.76 1.74 ± 0.75 1.81 ± 0.76 1.89 ± 0.82 1.75 ± 0.75 1.81 ± 0.73 1.89 ± 0.82 1.71 ± 0.75 1.62 ± 0.68 1.84 ± 0.82 1.81 ± 0.76 1.71 ± 0.61 1.84 ± 0.79 1.80 ± 0.80
p-value n.s. n.s. #0.043 n.s. n.s.
Data are presented as mean ± SD. Type 2 diabetics were excluded. P-values were calculated using additive, dominant (mm +mM vs. MM) and recessive (mm vs mM +MM) model of inheritance using linear regression
adjusted for age, gender and lnBMI (except for BMI). Analyses for smoking, alcohol and coffee consumption were adjusted for age and gender; ° = additive model of inheritance; # = dominant model of inheritance;
“=recessive model of inheritance; n.s. non-significant; significant P-values are highlighted in bold; N = number of individuals; BMI = Body Mass Index; WHR =Waist-Hip-Ratio.
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Rohde et al. BMC Genetics  (2015) 16:31 Page 5 of 8C-allele of rs782881 showed higher cigarette consume per
day (dominant model, P = 0.044; Table 2), we observed no
further relationship to the time period of smoking.
Additional analyses were performed to test the hypoth-
esis that variants within AKR1B10 are related to glucose,
insulin and lipid metabolism. Beside a few nominal associa-
tions of rs10232478, rs1834150, rs3778828 and rs4732036
with fasting plasma insulin values, 120 min plasma insulin
values, triglycerides levels and 120 min plasma glucose
levels (respectively), we did not detect evidence for any sig-
nificant associations (Additional file 1: Table S1). None of
the here reported P-values withstand correction for mul-
tiple testing (Bonferroni).
Association analysis in the replication cohort
In order to verify our results we performed linear regres-
sion analyses for rs10232478; rs782881 and rs1834150 in
an independent German cohort (N = 350). Despite failing
to reach statistical significance our replication analyses re-
vealed similar trends for higher disinhibition scores in
homozygous or heterozygous minor allele carriers (Table 3).
We observed a similar effect direction as compared to the
Sorbs at rs1834150 and a meta-analysis for rs1834150 re-
sulted in a combined P = 0.0096 (Table 4).
Interestingly, when analyzing a potential correlation of
the AKR1B10 SNPs with restraint scores we observed a
nominally significant relationship with increased restraint
at the same intragenic variants (rs1834150; rs782881) and
the 5′ UTR variant rs10232478 (all P ≤ 0.05; Table 3). In a
meta-analysis including the Sorbs and the replication co-
hort we confirmed a nominally significant association of
rs1834150 (P = 0.00728, Table 4) with restraint. Moreover,
we observed a nominal association of rs10232478 in theTable 3 Association analysis of AKR1B10 variants in the replic
AKR1B10 genotype
rs10232478 rs782881
Genotype (N) CC (50) CT (131) TT (99) CC (65)
age 27.14 ± 5.46 26.40 ± 4.87 26.53 ± 4.71 26.80 ± 5.54
p-value n.s. n.s.
BMI 27.6 ± 6.53 26.92 ± 6.16 27.21 ± 6.49 27.64 ± 6.67
p-value n.s. n.s.
association analysis with eating behavior factors
Disinhibition 6.64 ± 3.34 6.05 ± 3.12 6.33 ± 3.02 6.15 ± 3.11
p-value n.s. n.s.
Hunger 4.63 ± 2.87 5.57 ± 3.48 5.88 ± 3.26 4.80 ± 3.3
p-value °0.038 "0.036 n.s.
Restraint 7.85 ± 5.23 6.30 ± 4.41 5.55 ± 4.23 7.27 ± 4.91
p-value °0.010 "0.015 °0.027
Data are presented as mean± SD. Type 2 diabetics were excluded. P-values were calculat
model of inheritance using linear regression adjusted for age, sex and lnBMI (except for B
“=recessive model of inheritance; n.s. non-significant; significant P-values are highlighted5′ untranslated region with the eating behavior factor
hunger (P≤ 0.05; Table 3).
Discussion
The human AKR1B10 was shown to be associated with sev-
eral types of cancers including lung cancer [10] and liver
cancer [9]. AKR1B10 is highly expressed in the gastrointes-
tinal tract [1] and its expression is triggered via toxic alde-
hydes like acrolein and HNE present in many daily
nutrients [3,13] or through cigarette smoke [10,12]. The re-
ductase AKR1B10 is highly reactive towards this compo-
nents and may lead to their detoxification during digestion
[14]. Interestingly, Higueras-Matas and colleagues found an
inhibition of akr1b10 gene expression in rats more sensitive
to drugs like cocaine and ethanol in brain regions known to
regulate eating behavior [15]. While a potential role of
AKR1B10 in eating behavior seems plausible in the light of
these studies, its role in BMI, waist and hip circumference
or the influence on metabolic parameters was never ana-
lyzed so far. In the present study we therefore hypothesized
AKR1B10 to play a role in human eating behavior and
tested for a relationship to metabolic and anthropometric
variables. Using linear regression models we observed a re-
lationship of genetic variants within AKR1B10 and disinhib-
ition scores in the Sorbs along with similar directions in the
replication cohort. Disinhibition is a measure of the loss of
cognitive control during eating due to situational factors
[40]. This may result in overeating and a higher caloric
intake potentially contributing to an increase in body
weight [41]. Most of the studies suggest a positive associ-
ation between high disinhibition levels, BMI and weight
gain [42,43]. In contrast, we did not identify any relation-
ship to BMI but observed indications for lower waistation cohort
rs1834150
AC (146) AA (81) TT (56) TA (136) AA (82)
26.64 ± 4.97 26.91 ± 4.84 26.70 ± 4.82 26.43 ± 5.03 27.50 ± 5.01
n.s.
26.90 ± 5.93 27.36 ± 6.59 26.98 ± 5.94 27.34 ± 6.20 27.11 ± 6.59
n.s.
6.33 ± 3.22 6.01 ± 3.29 6.29 ± 3.06 6.56 ± 3.31 6.01 ± 3.21
n.s.
5.72 ± 3.51 5.76 ± 3.42 4.72 ± 3.18 5.99 ± 3.57 5.54 ± 3.37
n.s.
6.16 ± 4.22 5.42 ± 4.29 7.35 ± 5.14 5.99 ± 4.13 5.25 ± 4.06
°0.007 #0.049 "0.015
ed using additive, dominant (mm+mM vs. MM) and recessive (mm vs mM+MM)
MI); ° = additive model of inheritance; # = dominant model of inheritance;
in bold; N=number of individuals; BMI = Body Mass Index.
Table 4 Meta-analysis for association with eating behavior factors
Sorbs German cohort Combined
SNP Minor allele P-value β S.E. P-value β S.E. P-value Z-score Direction
Disinhibition
rs10232478 C 0.003 +0.071 0.024 0.948 −0.016 0.248 0.0194 +2.336 +−
rs782881 C 0.032 +0.357 0.167 0.977 −0.007 0.243 0.0888 +1.702 +−
rs1834150 T 0.006 +0.439 0.160 0.544 +0.153 0.252 0.0096 +2.591 ++
Restraint
rs10232478 C 0.334 +0.040 0.042 0.010 +0.993 0.385 0.0211 +2.306 ++
rs782881 C 0.185 +0.381 0.287 0.027 +0.816 0.367 0.0174 +2.378 ++
rs1834150 T 0.166 +0.382 0.276 0.007 +1.006 0.372 0.0072 +2.684 ++
Hunger
rs10232478 C 0.209 +0.030 0.024 0.038 −0.589 0.282 0.818 −0.230 +−
rs782881 C 0.542 +0.106 0.174 0.092 −0.487 0.288 0.6081 −0.513 +−
rs1834150 T 0.785 +0.046 0.168 0.237 −0.357 0.301 0.6459 −0.459 +−
P-values were calculated based on effect sizes from linear regression model using additive inheritance model. Significant P-values withstanding correction for
multiple testing are presented in bold. All data are adjusted for age, gender and lnBMI. All analyses were standardized to the minor allele.
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ition. This finding may be explained by the fact that re-
straint scores at rs1834150, rs782881 and rs10232478 are
increased as well. Restraint eaters tend to rigorously control
their body weight by permanently controlling their eating
habits. These individuals often count calories in order to
regulate the amount of food intake [40]. Since both, re-
straint and disinhibition, are not completely independent,
the observed increased restraint scores could probably
serve as a counteracting behavior against the disinhibition
effect [40,44]. One may argue that high restraint scores
were also found to be associated with a higher BMI [45].
However, it needs to be mentioned that restraint is not a
homogeneous measure but can be divided in two subscales
- rigid control (‘all or nothing’) and flexible control (‘more
or less’) [45,46]. While rigid control is associated with
higher BMI and eating disorders, flexible restraint is related
to decreased BMI and weight loss [43,46]. Furthermore, it
was demonstrated that individuals presenting rigid control
show increased restraint scores and simultaneously high
disinhibition scores which results in increased weight or
BMI. In contrast, flexible cognitive control was associated
with decreased BMI and weight [41,43,47]. We did not have
the opportunity to analyze restraint subscales, but neverthe-
less our data indicate a counteracting mechanism between
disinhibition and restraint which results in a decrease of
waist circumference, probably due to a highly flexible
cognitive control. Moreover, we found rs1834150 and
rs782881 related to intake of consumer goods in the Sorbs.
In particular, we show a nominal association at rs1834150
and higher coffee consumption per day and found
rs782881 correlated with an increased amount of cigarettes
per day. These findings, together with our results from the
eating behavior questionnaire FEV, suggest a potential roleof AKR1B10 in human eating behavior. However, it needs
to be acknowledged that none of the here observed rela-
tionships withstand a Bonferroni correction for multiple
testing, thus underscoring the possibility of false positive
findings. Therefore, although our data may indicate a role
of AKR1B10 in eating behavior, intake of consumer goods
and waist circumference, they need to be interpreted
with caution.
Further, we tested for a potential relationship of the
AKR1B10 genetic variants to various variables of the
glucose and insulin metabolism as well as lipid profiles.
Beside several, rather occasional, non-significant correla-
tions we did not identify any consistent evidence for sig-
nificant associations with the tested SNPs.
Despite some interesting results, our study is limited at
several aspects. (i) Although we present a second inde-
pendent replication cohort the sample size of our study is
rather small which may lead to false positive and false
negative results. (ii) There is a large discrepancy in the
male/female ratio and in age between the study cohorts
which may have, in terms of different eating behavior pat-
terns between men and women, influenced our results as
demonstrated by others [48-50]. However, we used gender
as covariate in our analysis whereby the influence of dis-
crepancy in the male/female ratio on the results was taken
into account. (iii) Due to the lack of data for metabolic
variables and consumer goods in the replication cohort we
cannot conduct meta-analysis for both sample sets. (iv)
While the German version of the three factor eating
questionaire (FEV) is validated as reported by Pudel V &
Westenhoefer J [31] with internal reliability of the three
scales (between r = 0.75 and 0.87) and similar data on
internal reliability observed in the Sorbs (Cronbach’s
alpha coefficients: disinhibition = 0.744; restraint = 0.856;
Rohde et al. BMC Genetics  (2015) 16:31 Page 7 of 8hunger = 0.745), questions related to consumer goods were
not validated. Therefore, our data on consumer goods need
to be interpreted with caution.
In conclusion, our data in regard to eating behavior fac-
tors support our hypothesis that AKR1B10 may be a po-
tential contributor to human eating behavior. However,
our data need to be cautiously interpreted and larger
studies are definitely warranted to replicate and verify the
observed effects.
Conclusions
To the best of our knowledge this is the first evidence for
an association of AKR1B10 with eating behavior. The
established role of AKR1B10 in cancers via influencing im-
portant signaling pathways like the retinoid acid metabol-
ism [6,8] together with the here presented potential role in
human eating behavior may give rise to further scenarios
through which AKR1B10 may function in other pathways.
Additional file
Additional file 1: Table S1. Association analysis of AKR1B10 variants in
the Sorbs population.
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